SE9901237D0 - Novel use - Google Patents

Novel use

Info

Publication number
SE9901237D0
SE9901237D0 SE9901237A SE9901237A SE9901237D0 SE 9901237 D0 SE9901237 D0 SE 9901237D0 SE 9901237 A SE9901237 A SE 9901237A SE 9901237 A SE9901237 A SE 9901237A SE 9901237 D0 SE9901237 D0 SE 9901237D0
Authority
SE
Sweden
Prior art keywords
hydrogen
fluorophenyl
phenyl
novel use
coch2nh2
Prior art date
Application number
SE9901237A
Other languages
English (en)
Swedish (sv)
Inventor
Hans Basun
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9901237A priority Critical patent/SE9901237D0/xx
Publication of SE9901237D0 publication Critical patent/SE9901237D0/xx
Priority to AU39941/00A priority patent/AU3994100A/en
Priority to PCT/SE2000/000643 priority patent/WO2000059496A1/en
Priority to ARP000101558A priority patent/AR023389A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9901237A 1999-04-06 1999-04-06 Novel use SE9901237D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9901237A SE9901237D0 (sv) 1999-04-06 1999-04-06 Novel use
AU39941/00A AU3994100A (en) 1999-04-06 2000-04-04 Use of low affinity nmda antagonists for the treatment of headache
PCT/SE2000/000643 WO2000059496A1 (en) 1999-04-06 2000-04-04 Use of low affinity nmda antagonists for the treatment of headache
ARP000101558A AR023389A1 (es) 1999-04-06 2000-04-05 Nuevo uso

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901237A SE9901237D0 (sv) 1999-04-06 1999-04-06 Novel use

Publications (1)

Publication Number Publication Date
SE9901237D0 true SE9901237D0 (sv) 1999-04-06

Family

ID=20415133

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901237A SE9901237D0 (sv) 1999-04-06 1999-04-06 Novel use

Country Status (4)

Country Link
AR (1) AR023389A1 (xx)
AU (1) AU3994100A (xx)
SE (1) SE9901237D0 (xx)
WO (1) WO2000059496A1 (xx)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135206T1 (de) * 1988-08-12 1996-03-15 Astra Ab Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung
DK0624569T3 (da) * 1991-02-28 1998-10-26 Merrell Pharma Inc MMDA-antagonister
DK0633879T3 (da) * 1992-04-03 1998-09-28 Astra Ab Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
WO1995006468A1 (en) * 1993-09-01 1995-03-09 Smithkline Beecham Corporation Method for treating migraine headaches
IS4233A (is) * 1993-12-22 1995-06-23 Astra Aktiebolag Misleit hringtengd efnasambönd
DE19510189A1 (de) * 1995-03-21 1996-09-26 Hartmut Dr Goebel Verwendung von Amantadin
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
WO1998019674A2 (en) * 1996-11-05 1998-05-14 Head Explorer Aps A method for treating tension-type headache

Also Published As

Publication number Publication date
AR023389A1 (es) 2002-09-04
WO2000059496A1 (en) 2000-10-12
AU3994100A (en) 2000-10-23

Similar Documents

Publication Publication Date Title
NL300877I2 (nl) obeticholzuur
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
NO20074657L (no) Nitrogenholdige aromatiske ringforbindelser
NO20101069L (no) Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva
GB9801690D0 (en) Therapeutic agents
NO20033385L (no) Fuserte heterocykliske forbindelser
NO20060314L (no) Nicotinamid-derivater anvendbare som PDE4-inhibitorer
DE60121461D1 (de) Kondensierte pyridoindolderivate
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
ATE316962T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
ATE293111T1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE60222465D1 (de) Pyrazolopyridin-derivate als antiherpesmittel
ATE191465T1 (de) Carbamoylcarbonsäureamide
NO20033049L (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin
SE9704770D0 (sv) New use
SE9901237D0 (sv) Novel use
DE60110233D1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
ATE366727T1 (de) Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE374751T1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern